LifeStance Health Price to Free Cash Flow Ratio 2020-2024 | LFST
Historical price to free cash flow ratio values for LifeStance Health (LFST) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| LifeStance Health Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-11-06 | 7.13 | 0.00 | |
| 2024-06-30 | 4.91 | $-0.05 | 0.00 |
| 2024-03-31 | 6.17 | $-0.18 | 0.00 |
| 2023-12-31 | 7.83 | $-0.16 | 0.00 |
| 2023-09-30 | 6.87 | $-0.10 | 0.00 |
| 2023-06-30 | 9.13 | $-0.03 | 0.00 |
| 2023-03-31 | 7.43 | $-0.05 | 0.00 |
| 2022-12-31 | 4.94 | $-0.07 | 0.00 |
| 2022-09-30 | 6.62 | $-0.18 | 0.00 |
| 2022-06-30 | 5.56 | $-0.26 | 0.00 |
| 2022-03-31 | 10.11 | $-0.33 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.939B | $1.056B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $20.553B | 12.43 |
| Quest Diagnostics (DGX) | United States | $17.434B | 17.67 |
| DaVita (DVA) | United States | $12.330B | 15.95 |
| Encompass Health (EHC) | United States | $10.431B | 24.59 |
| Chemed (CHE) | United States | $8.349B | 25.66 |
| Elanco Animal Health (ELAN) | United States | $7.168B | 17.06 |
| RadNet (RDNT) | United States | $5.281B | 125.26 |
| Option Care Health (OPCH) | United States | $3.902B | 18.49 |
| Amedisys (AMED) | United States | $3.169B | 22.56 |
| Astrana Health (ASTH) | United States | $2.900B | 45.45 |
| Addus HomeCare (ADUS) | United States | $2.341B | 27.46 |
| U.S Physical Therapy (USPH) | United States | $1.436B | 37.81 |
| Pennant (PNTG) | United States | $1.099B | 44.44 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.080B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.227B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.014B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.013B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |